Literature DB >> 16101829

Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.

N Bandoh1, T Ogino, H S Cho, S Y Hur, J Shen, X Wang, S Kato, N Miyokawa, Y Harabuchi, S Ferrone.   

Abstract

Delta (Y), MB1 (X), and Z are the three catalytic beta-subunits located in the inner rings of the constitutive proteasome, an intracellular multicatalytic complex responsible for the generation of peptides presented by human leukocyte antigen (HLA) class I antigens to T cells. When cells are incubated with interferon-gamma, delta (Y), MB1 (X), and Z are replaced by LMP2, LMP7, and LMP10, respectively, leading to the expression of immunoproteasome which generates peptides with increased affinity for HLA class I antigens. The characterization of the expression of constitutive proteasome and immunoproteasome subunits in cells, normal tissues, and malignant lesions has been hampered by the lack or limited availability of constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies (mAbs), which are suitable for immunohistochemical staining. To overcome this limitation, we generated human delta (Y), MB1 (X), Z, LMP2, LMP7, and LMP10-specific mAb-secreting hybridomas from BALB/c mice immunized with peptides and recombinant fusion proteins. The mAbs SY-5, SJJ-3, NB-1, SY-1, HB-2, and TO-7 were shown to be specific for delta (Y), MB1 (X), Z, LMP2, LMP7, and LMP10, respectively, as they react specifically with the corresponding molecules when tested with a human B lymphoid LG2 cell lysate in Western blotting and with the peptide derived from each molecule in enzyme-linked immunosorbent assay. The reactivity of the six mAbs with the corresponding intracellular antigens resulted in intracellular staining when the mAbs were tested with microwave-treated and saponin-permeabilized cells in indirect immunofluorescence and with formalin-fixed, paraffin-embedded tissue sections in immunohistochemical reactions. These results suggest that the constitutive proteasome and immunoproteasome subunit-specific mAbs we have developed are useful probes to characterize the expression of proteasome subunits in normal tissues and in pathological lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101829     DOI: 10.1111/j.1399-0039.2005.00462.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  39 in total

1.  Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.

Authors:  Yan Liu; Yoshihiro Komohara; Natalie Domenick; Masasuke Ohno; Maki Ikeura; Ronald L Hamilton; Craig Horbinski; Xinhui Wang; Soldano Ferrone; Hideho Okada
Journal:  Cancer Immunol Immunother       Date:  2011-11-08       Impact factor: 6.968

2.  Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma.

Authors:  Vito Racanelli; Patrizia Leone; Maria Antonia Frassanito; Claudia Brunetti; Federico Perosa; Soldano Ferrone; Franco Dammacco
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

3.  STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.

Authors:  Raghvendra M Srivastava; Sumita Trivedi; Fernando Concha-Benavente; Jie Hyun-Bae; Lin Wang; Raja R Seethala; Barton F Branstetter; Soldano Ferrone; Robert L Ferris
Journal:  Cancer Immunol Res       Date:  2015-05-13       Impact factor: 11.151

4.  Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.

Authors:  Michael S Leibowitz; Pedro A Andrade Filho; Soldano Ferrone; Robert L Ferris
Journal:  Cancer Immunol Immunother       Date:  2011-01-05       Impact factor: 6.968

5.  HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.

Authors:  Sara I Pai; J Jack Lee; Thomas E Carey; William H Westra; Soldano Ferrone; Charles Moore; Marina B Mosunjac; Dong M Shin; Robert L Ferris
Journal:  Oral Oncol       Date:  2017-12-28       Impact factor: 5.337

6.  MHC class I-related antigen-processing machinery component defects in feline mammary carcinoma.

Authors:  Alessandra Favole; Paolo Cascio; Fulvia Cerruti; Alessandra Sereno; Massimiliano Tursi; Alessandro Tomatis; Cristina Della Beffa; Soldano Ferrone; Enrico Bollo
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

7.  Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.

Authors:  Chien-Chung Chang; Giuseppe Pirozzi; Shao-Hsuan Wen; I-Hsin Chung; Bau-Lin Chiu; Simona Errico; Monica Luongo; Maria Luisa Lombardi; Soldano Ferrone
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

8.  Expression pattern of immunoproteasome subunits in human thymus.

Authors:  Kwon Ik Oh; Jae Nam Seo
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

9.  Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Authors:  Fabio Morandi; Lizzia Raffaghello; Giovanna Bianchi; Francesca Meloni; Annalisa Salis; Enrico Millo; Soldano Ferrone; Vincenzo Barnaba; Vito Pistoia
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

10.  Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.

Authors:  Chin-Hsuan Hsieh; Ya-Jan Hsu; Chien-Chung Chang; Hsin-Chun Liu; Kun-Lung Chuang; Cheng-Keng Chuang; See-Tong Pang; Kenichiro Hasumi; Soldano Ferrone; Shuen-Kuei Liao
Journal:  Cancer Immunol Immunother       Date:  2008-08-15       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.